ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Millers, Jensen, Bereblum Win $100,000 GM awards

June 6, 1980

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005